title: Antitachycardia pacing for reduction of implantable cardioverter-defibrillator shocks.
abstract: Antitachycardia pacing (ATP) strategies represent safe, effective, and painless therapy for ventricular tachyarrhythmias, with a large body of clinical evidence supporting their routine use in both primary and secondary implantable cardioverter-defibrillator recipients. This article details the evidence supporting the use of standardized and validated ATP strategies for primary prevention patients and the conceptual framework to design effective ATP strategy for secondary prevention patients.
authors.affiliation: Cleveland Clinic, Heart and Vascular Institute, Cardiac Electrophysiology and Pacing, Cleveland, Ohio. Electronic address: cantild@ccf.org.
authors.forename: Daniel J
authors.initials: DJ
authors.lastname: Cantillon
authors.affiliation: Cleveland Clinic, Heart and Vascular Institute, Cardiac Electrophysiology and Pacing, Cleveland, Ohio.
authors.forename: Bruce L
authors.initials: BL
authors.lastname: Wilkoff
mesh_terms: D002304:Cardiac Pacing, Artificial; D017147:Defibrillators, Implantable / Q000009:adverse effects*; D006801:Humans; D013610:Tachycardia / Q000628:therapy*
keywords: Antitachycardia pacing; Implantable cardioverter-defibrillator; Sudden cardiac death